Bo He

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Multidrug Resistant

Reactive Oxygen Species

Transcription Factor

Top Venues

Pharmaceuticals (Basel, Switzerland)

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Bo He, Zhao Huang, Siyuan Qin, Peilan Peng, Xirui Duan, Longqin Wang, Qin Ye, Kui Wang, Jingwen Jiang, Bowen Li, Rui Liu, Canhua Huang
Enhanced SLC35B2/SAV1 sulfation axis promotes tumor growth by inhibiting Hippo signaling in HCC. Hepatology (Baltimore, Md.) (2024)
Lei Li, Ping Jin, Yueyue Guan, Maochao Luo, Yu Wang, Bo He, Bowen Li, Kai He, Jiangjun Cao, Canhua Huang, Jingquan Li, Zhisen Shen
Exploiting Polyphenol-Mediated Redox Reorientation in Cancer Therapy. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Lei Li, Ping Jin, Yueyue Guan, Maochao Luo, Yu Wang, Bo He, Bowen Li, Kai He, Jiangjun Cao, Canhua Huang, Jingquan Li, Zhisen Shen
Exploiting Polyphenol-Mediated Redox Reorientation in Cancer Therapy. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Lei Li, Ping Jin, Yueyue Guan, Maochao Luo, Yu Wang, Bo He, Bowen Li, Kai He, Jiangjun Cao, Canhua Huang, Jingquan Li, Zhisen Shen
Exploiting Polyphenol-Mediated Redox Reorientation in Cancer Therapy. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Lei Li, Ping Jin, Yueyue Guan, Maochao Luo, Yu Wang, Bo He, Bowen Li, Kai He, Jiangjun Cao, Canhua Huang, Jingquan Li, Zhisen Shen
Exploiting Polyphenol-Mediated Redox Reorientation in Cancer Therapy. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)